Episode

Private Credit Woes & Psychedelic Wins 4/20/26

Podcast: Squawk Pod
Published: Apr 20, 2026
Duration seconds: 2840
Processing state: not_requested
Canonical source: https://www.cnbc.com
Audio: https://dts.podtrac.com/redirect.mp3/cnbc.simplecastaudio.com/2abef7ca-625f-4c74-9157-968d7da67c81/episodes/51e593d1-b7d7-4954-bc9a-a71ea83fd11b/audio/128/default.mp3?aid=rss_feed&awCollectionId=2abef7ca-625f-4c74-9157-968d7da67c81&awEpisodeId=51e593d1-b7d7-4954-bc9a-a71ea83fd11b&feed=VHAcgaw_
JSON: /v1/public/podcasts/squawk-pod-254103/episodes/private-credit-woes-psychedelic-wins-4-20-26
Markdown: /podcast/squawk-pod-254103/private-credit-woes-psychedelic-wins-4-20-26.md

Actions

POST https://stenobird.com/v1/public/podcasts/squawk-pod-254103/episodes/private-credit-woes-psychedelic-wins-4-20-26/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/squawk-pod-254103/private-credit-woes-psychedelic-wins-4-20-26.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

As concerns mount regarding the health of the private credit ecosystem, Oaktree Capital Management co-chairman Howard Marks offers perspective–and some investing advice–when it comes to private lending. Former FDA Commissioner Dr. Scott Gottlieb discusses Eli Lilly’s deal to expand its cancer treatment pipeline as well as President Trump’s executive order on therapeutic psychedelics. Plus, Kevin Warsh’s Fed Chair nomination hearing is this week, and Anthropic’s Mythos is at work within the NSA, despite being blacklisted by the US government. Steve Liesman 14:36 Howard Marks 23:54 Dr. Scott Gottlieb 41:27 In this episode: Steve Liesman, @steveliesman Andrew Ross Sorkin, @andrewrsorkin Becky Quick, @BeckyQuick Joe Kernen, @JoeSquawk Katie Kramer, @Kramer_Katie